Moderna cuts 2025 revenue guidance, stock plunges - Investing.com

2 days ago · Investing.com -- Moderna shares plunged by more than 17% premarket Monday after the company lowered its 2025 revenue forecast. The biotech company revised its …

17%
OFF

Moderna Cuts 2025 Revenue Guidance, Stock Plunges - Investing.com

2 weeks from now

2 days ago · Investing.com -- Moderna shares plunged by more than 17% premarket Monday after the company lowered its 2025 revenue forecast. The biotech company revised its …

investing.com

9%
OFF

Moderna Shares Drop After Cutting Research Budget

2 weeks from now

Sep 12, 2024 · Moderna (NASDAQ: MRNA) stock fell 5.9% premarket Thursday trading following its announcement of cuts to its research and development (R&D) budget.. The drugmaker …

investing.com

20%
OFF

Moderna's $1 Billion Revenue Forecast Cut Sends Stock

2 weeks from now

2 days ago · Shares of Moderna dropped more than 20% intraday to $33.44, more than erasing gains last week after the first bird-flu death was reported in the U.S. The stock has lost about …

investopedia.com

$1
OFF

Moderna Crashes After Slashing Its R&D Budget By $1.1 Billion

2 weeks from now

Sep 16, 2024 · Moderna stock has dropped off markedly after shooting to a record high in August 2021. Shares hit a 2024 high in late May. Since then, shares have lost more than half their …

investors.com

18%
OFF

Moderna’s Stock Slides As It Slashes Research Spending, Trims Pipeline

2 weeks from now

Sep 12, 2024 · Moderna Inc.’s stock fell more than 18% Thursday after the company said it will rein in its research-and-development spending and trim its pipeline as it looks to shake off the …

marketwatch.com

20%
OFF

Moderna Shares Tumble On Slashed Sales Guidance

2 weeks from now

2 days ago · Shares in Moderna dropped by more than 20% Monday morning after the biotechnology company slashed its revenue guidance for 2025 by $1 billion. Moderna now …

biopharmadive.com

$1
OFF

Moderna's Pain Continues As Downgrades Mount Post R&D Day

2 weeks from now

Sep 16, 2024 · Moderna said Thursday it plans to slash its research and development budget by $1.1 billion in 2027 as it focuses on launching 10 new products over the next three years. ...

investors.com

20%
OFF

Moderna Stock Plummets On Cost-Cutting Measures

2 weeks from now

Sep 12, 2024 · Shares of Moderna Inc (NASDAQ:MRNA) are plummeting today, after the biotech giant announced it was slashing its research budget by about 20%. The company also teased …

schaeffersresearch.com

21%
OFF

Moderna Crashes 21% After Slashing 2024-25 Guidance

2 weeks from now

2 days ago · Moderna also cut its 2025 outlook and now projects just $1.5 billion to $2.5 billion, well below its prior view for $2.5 billion to $3.5 billion. Moderna stock crashed 20.7% to 33.50.

investors.com

$1
OFF

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

2 weeks from now

Sep 13, 2024 · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

investopedia.com

20%
OFF

Moderna Stock Plunges Nearly 20% As Company Reports Poor …

2 weeks from now

Sep 12, 2024 · Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development (R&D) budget by about 20% over the next three years, a result of …

yahoo.com

18%
OFF

Moderna Trims Research Budget, Stock Falls To Lowest Level In 10 …

2 weeks from now

Sep 12, 2024 · Moderna (NASDAQ:MRNA) shares fell roughly 18% on Thursday to its lowest in 10 months after the vaccine maker detailed plans to cut its annual R&D expense by $1.1B …

seekingalpha.com

10%
OFF

Moderna Stock Falls After Co Trims Research Budget

2 weeks from now

Moderna (NASDAQ:MRNA) shares fell roughly 10% premarket on Thursday after the vaccine maker detailed plans to cut its annual R&D expense by $1.1B starting in 2027. The company …

msn.com

21%
OFF

Why Moderna Stock Just Crashed 21% | The Motley Fool

2 weeks from now

2 days ago · CEO Stéphane Bancel said Moderna has cut its "cash operating cost by over 25 percent compared to 2023" and plans to make further cost cuts of $1 billion in 2025 and $500 …

fool.com

21%
OFF

Moderna Crashes 21%. 'No Inflection In Sight' After Guidance Cut, …

2 weeks from now

2 days ago · Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 …

yahoo.com

9%
OFF

Moderna Shares Drop After Cutting Research Budget

2 weeks from now

Sep 12, 2024 · Moderna (NASDAQ:MRNA) stock fell 5.9% premarket Thursday trading following its announcement of cuts to its research and development (R&D) budget. The drugmaker …

10xfundings.com

FAQs about Moderna cuts 2025 revenue guidance, stock plunges - Investing.com Coupon?

Why is Moderna (mRNA) stock plunging?

Moderna (MRNA) stock is plunging Thursday after the COVID-19 vaccine maker announced plans to slash research and development (R&D) expenses and instead focus on receiving approvals for the many drugs in its pipeline. Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. ...

Why did Moderna cut its research and development budget?

The jab passed vital scientific checks in June 2024. To conserve cash, Moderna has slashed its research and development budget, cutting long-term spending by 20 percent between 2025 and 2028. The company also delayed its break-even timeline from 2026 to 2028. Sales for the RSV vaccine, called mRESVIA, were "negligible," the company said. ...

Why did Moderna stock fall 10% premarket?

Moderna (NASDAQ: MRNA) shares fell roughly 10% premarket on Thursday after the vaccine maker detailed plans to cut its annual R&D expense by $1.1B starting in 2027. The company is undertaking portfolio prioritization and cost efficiencies to reduce R&D expense by $1.1 billion, from $4.8 billion in 2024E to $3.6-3.8 billion in 2027. ...

Why did Moderna stock plunge Thursday?

Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over the next three years, a result of low sales projections and poor vaccine sales. Most Read from Fast Company When does iOS 18 come out? Date and time you can download the new iPhone operating system around the world ...

Is Moderna stock going down a lot?

Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated investors on its 2024 performance and released new guidance for 2025. ...

Is Moderna cutting its research & development expenses in 2025?

The biotech company said it is cutting its expected research-and-development expenses for 2025 through 2028 by 20%, to $16 billion for the period. Tempering longer-term expectations for new product launches, Moderna ...